Pharmacogenomics
How genes can change the way medicines work, and how a saliva PGx report helps a clinician choose dose.
Pharmacogenomics, often called PGx, looks at how your DNA may affect response to a medicine. Two people can take the same drug and have very different results. One may need a lower dose. Another may get little benefit. A third may have a side effect that was hard to predict from the prescription alone.
At 30M Genomics this is the core test we run today. You collect saliva with a swab. The lab reads FDA-approved, India-relevant markers. The report uses CPIC clinical practice guidelines so a clinician sees gene–drug notes they can act on. AI helps organise a multi-marker report. It does not replace a doctor.
- Saliva swab. No blood draw.
- FDA-approved markers, not a research-only gene dump.
- Indian-population context, because allele frequencies differ.
- CPIC-guided dosing notes for the clinician.
- Report target: within 24 hours after the lab receives the sample.
PGx is not a diagnosis and it is not a reason to change a medicine on your own. Share the PDF with the clinician who prescribed the drug. Authorised doctors can also use Aiyra for a walkthrough of the 30M report.